Helsinn appoints Dr Melanie Rolli as Group Chief Operating

Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer Lugano, Switzerland, May 19, 2022 – Helsinn Group, a fully integrated, global biopharma...

Related Keywords

Germany ,United States ,China ,California ,Lugano ,Ticino ,Switzerland ,Heidelberg ,Baden Wüberg ,Ireland ,Mannheim ,Spain ,La Jolla ,Barcelona ,Comunidad Autonoma De Cataluna ,Melanie Rolli ,Paola Bonvicini ,Giorgio Calderari ,Novartis Pharma ,Head Of Medical Affairs ,Linkedin ,Twitter ,Dr Melanie Rolli As Group ,Helsinn Birex Pharmaceuticals Ltd ,Group Drug Development ,Novartis Oncology Business Unit For Development Functions ,Helsinn Group ,Senior Leadership Team ,Helsinn As Group ,Research Institute For Molecular ,Department Of Women Health ,University Medical Hospital ,Group Head Of Communication ,University Of Heidelberg ,Group Chief Operating ,Group Chief Operating Officer ,Fully Integrated Targeted Therapy ,Senior Leadership ,Portfolio Integration ,Novartis Oncology Business Unit ,Chief Executive Officer ,Piqur Therapeutics ,Development Leadership Team ,Novartis Oncology ,Medical Affairs ,Global Head Medical Safety ,Group Drug ,Medical School ,Clinician Medical ,Surgical Oncology ,Postdoctoral Fellowship ,Experimental Medicine ,Helsinn Birex Pharmaceuticals ,Media Contact ,Helsinn Healthcare Sa ,Helsinn ,R Melanie Rolli ,Elix Therape ,